光动力疗法和心血管疾病
Aleksander Oskroba1, Dorota Bartusik-Aebisher2, Angelika Myśliwiec3
1Science Club, Faculty of Medicine, Medical University of Lublin, 20-059 Lublin, Poland.
International journal of molecular sciences
|March 13, 2024
概括
光动力疗法 (PDT) 显示出治疗动脉样硬化等心血管疾病的潜力,尽管其在心脏病学中的临床应用目前有限. 这篇评论探讨了PDT.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
- 照相医疗 (photomedicine) 是一种医学.
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因,其中心脏病发作和中风最为普遍.
- 动脉样硬化严重影响心血管疾病的发展和管理.
- 光动力疗法 (PDT) 是各种疾病的既定治疗方法,但在心脏病学中未得到充分利用.
研究的目的:
- 审查当前光动力疗法 (PDT) 在治疗心血管疾病方面的有效性.
- 总结一下PDT心脏病应用中常用的光敏剂.
主要方法:
- 对心血管疾病治疗中的光动力疗法现有研究的文献综述.
- 对有关心脏病治疗的PDT疗效和光敏感剂在心脏病中的使用的实验和临床数据的分析.
- 综合发现,以描述PDT的治疗潜力和当前局限性.
主要成果:
- 光动力学疗法 (PDT) 在心血管应用的临床前和体外模型中显示出前景.
- 在心脏病学中PDT的临床应用仍然很少,大多数证据来自实验环境.
- 特定的光敏感剂已被确定为其在心血管疾病的PDT中的潜在用途.
结论:
- 光动力疗法 (PDT) 为心血管疾病,特别是动脉样硬化提供了潜在的治疗途径.
- 需要进一步的临床研究和开发,以使PDT成为心脏病学中的标准治疗.
- 了解光敏剂的特性对于优化心血管医学中的PDT至关重要.
相关概念视频
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
164
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
164
01:46Electron Transport Chain: Complex I and II
13.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.2K